These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 12649296

  • 1. Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.
    Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, Lübbert H, Albuquerque EX, Maelicke A.
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1024-36. PubMed ID: 12649296
    [Abstract] [Full Text] [Related]

  • 2. The allosteric potentiation of nicotinic acetylcholine receptors by galantamine is transduced into cellular responses in neurons: Ca2+ signals and neurotransmitter release.
    Dajas-Bailador FA, Heimala K, Wonnacott S.
    Mol Pharmacol; 2003 Nov; 64(5):1217-26. PubMed ID: 14573772
    [Abstract] [Full Text] [Related]

  • 3. Galantamine increases excitability of CA1 hippocampal pyramidal neurons.
    Oh MM, Wu WW, Power JM, Disterhoft JF.
    Neuroscience; 2006 Nov; 137(1):113-23. PubMed ID: 16242849
    [Abstract] [Full Text] [Related]

  • 4. Galantamine is an allosterically potentiating ligand of the human alpha4/beta2 nAChR.
    Samochocki M, Zerlin M, Jostock R, Groot Kormelink PJ, Luyten WH, Albuquerque EX, Maelicke A.
    Acta Neurol Scand Suppl; 2000 Nov; 176():68-73. PubMed ID: 11261808
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    Caricati-Neto A, D'angelo LC, Reuter H, Hyppolito Jurkiewicz N, Garcia AG, Jurkiewicz A.
    Eur J Pharmacol; 2004 Oct 25; 503(1-3):191-201. PubMed ID: 15496314
    [Abstract] [Full Text] [Related]

  • 6. Localization by site-directed mutagenesis of a galantamine binding site on α7 nicotinic acetylcholine receptor extracellular domain.
    Ludwig J, Höffle-Maas A, Samochocki M, Luttmann E, Albuquerque EX, Fels G, Maelicke A.
    J Recept Signal Transduct Res; 2010 Dec 25; 30(6):469-83. PubMed ID: 21062106
    [Abstract] [Full Text] [Related]

  • 7. Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.
    Lopes C, Pereira EF, Wu HQ, Purushottamachar P, Njar V, Schwarcz R, Albuquerque EX.
    J Pharmacol Exp Ther; 2007 Jul 25; 322(1):48-58. PubMed ID: 17446300
    [Abstract] [Full Text] [Related]

  • 8. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.
    Neuropharmacology; 2006 Dec 25; 51(7-8):1181-91. PubMed ID: 17011596
    [Abstract] [Full Text] [Related]

  • 9. Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity.
    Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S.
    Biochem Biophys Res Commun; 2004 Dec 17; 325(3):976-82. PubMed ID: 15541385
    [Abstract] [Full Text] [Related]

  • 10. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
    Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S.
    Brain Res; 2005 Feb 08; 1033(2):186-93. PubMed ID: 15694923
    [Abstract] [Full Text] [Related]

  • 11. Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
    Schilström B, Ivanov VB, Wiker C, Svensson TH.
    Neuropsychopharmacology; 2007 Jan 08; 32(1):43-53. PubMed ID: 16641937
    [Abstract] [Full Text] [Related]

  • 12. Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons.
    Kume T, Sugimoto M, Takada Y, Yamaguchi T, Yonezawa A, Katsuki H, Sugimoto H, Akaike A.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):77-85. PubMed ID: 16313899
    [Abstract] [Full Text] [Related]

  • 13. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system.
    Santos MD, Alkondon M, Pereira EF, Aracava Y, Eisenberg HM, Maelicke A, Albuquerque EX.
    Mol Pharmacol; 2002 May 19; 61(5):1222-34. PubMed ID: 11961141
    [Abstract] [Full Text] [Related]

  • 14. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ, Zwart R, Bermudez I, van Kleef RG, Groot-Kormelink PJ, Vijverberg HP.
    Eur J Pharmacol; 2005 Feb 21; 509(2-3):97-108. PubMed ID: 15733544
    [Abstract] [Full Text] [Related]

  • 15. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors.
    Arias E, Gallego-Sandín S, Villarroya M, García AG, López MG.
    J Pharmacol Exp Ther; 2005 Dec 21; 315(3):1346-53. PubMed ID: 16144975
    [Abstract] [Full Text] [Related]

  • 16. Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems.
    Noda Y, Mouri A, Ando Y, Waki Y, Yamada SN, Yoshimi A, Yamada K, Ozaki N, Wang D, Nabeshima T.
    Int J Neuropsychopharmacol; 2010 Nov 21; 13(10):1343-54. PubMed ID: 20219155
    [Abstract] [Full Text] [Related]

  • 17. Effect of subchronic galantamine treatment on neuronal nicotinic and muscarinic receptor subtypes in transgenic mice overexpressing human acetylcholinesterase.
    Svedberg MM, Bednar I, Nordberg A.
    Neuropharmacology; 2004 Sep 21; 47(4):558-71. PubMed ID: 15380373
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of nicotinic acetylcholine receptors protects motor neurons.
    Nakamizo T, Kawamata J, Yamashita H, Kanki R, Kihara T, Sawada H, Akaike A, Shimohama S.
    Biochem Biophys Res Commun; 2005 May 20; 330(4):1285-9. PubMed ID: 15823582
    [Abstract] [Full Text] [Related]

  • 19. Nefiracetam and galantamine modulation of excitatory and inhibitory synaptic transmission via stimulation of neuronal nicotinic acetylcholine receptors in rat cortical neurons.
    Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Fukunaga K, Narahashi T.
    Neuroscience; 2009 May 05; 160(2):484-91. PubMed ID: 19272425
    [Abstract] [Full Text] [Related]

  • 20. Nicotinic acetylcholine receptor-mediated neuroprotection by donepezil against glutamate neurotoxicity in rat cortical neurons.
    Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H, Akaike A.
    J Pharmacol Exp Ther; 2003 Aug 05; 306(2):772-7. PubMed ID: 12734391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.